Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04314050
Other study ID # Urinery Catheter Discomfort
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 10, 2020
Est. completion date July 10, 2020

Study information

Verified date November 2021
Source Ankara Diskapi Training and Research Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators aimed to compare the effects of tramadol and dexmedetomidine, which are commonly used in anesthesia, on preventing catheter-related bladder discomfort.


Description:

Urinary catheterization is an attempt frequently used in many surgeries, emergency services or intensive care units, especially urinary surgeries to facilitate urine output or evaluate urine output. However, as a result of urinary catheter application, most patients may develop some symptoms like pain, burning sensation and the urge to urinate constantly in the suprapubic region that the investigators call this catheter-related bladder discomfort (CRBD). The incidence of CRBD can increase 47 to 90% in the postoperative period. The main reason of CRBD is involuntary contractions caused by muscarinic receptors, especially type 3 (M3) receptors. Therefore, antimuscarinic drugs are used to prevent and treat CRBD. Studies have shown that many drugs such as ketamine, tolterodine, oxybutynin, gabapentin, pregabalin, butylscopolamine, tramadol, dexmedetomidine are effective in preventing CRBD. Their common feature is antimuscarinic effects. However, no definitive conclusion could be reached for routine use, due to the low number of samples in the studies, surgical differences or some anticholinergic and sedative side effects. Additionally, oxybutynin, tolterodine, gabapentin, and pregabalin are only preoperatively administered orally. So more research is needed to find the ideal agent to prevent CRBD. Tramadol is frequently used for moderate pain in surgeries. It is a centrally acting synthetic opioid analgesic that has an inhibitory effect on M1 and M3 muscarinic receptors. Tramadol has proven to be effective in reducing the severity and frequency of ICBR in intraoperative use. However, like other opioids, it can have side effects such as nausea-vomiting and sedation. Dexmedetomidine is a selective alpha-2 adrenoceptor agonist that has analgesic, sympatholytic and sedative properties. In recent studies, it has been reported that dexmedetomidine is associated with the pathophysiology of CRBD by inhibiting type-3 (M3) muscarinic receptor which has beneficial effects in preventing CRBD in intraoperative use. Dexmedetomidine decreases the frequency of CRBD by 30%. The first purpose of the study is to compare the effects of dexmedetomidine and tramadol on CRBD. Secondarily, the investigators aimed to compare them for their side effects.


Recruitment information / eligibility

Status Completed
Enrollment 135
Est. completion date July 10, 2020
Est. primary completion date June 10, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - Patients between the ages of 18 and 70 years - American Society of Anesthesiologists I or II - Scheduled to undergo retrograde intrarenal surgery - Scheduled to apply urinary catheter intraoperatively Exclusion Criteria: - History of bladder outlet obstruction (Bening prostatic hypertrophy) - History of neurogenic bladder - History of psychiatric illness - Obese patient - Patients whose urinary catheter cannot be inserted - Patients who had previously urinary catheters

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Tramadol
tramadol and paracetamol will perform
Dexmedetomidine
dexmedetomidine and paracetamol will perform
Other:
control
paracetamol will perform

Locations

Country Name City State
Turkey Diskapi Training and Research Hospital Ankara

Sponsors (1)

Lead Sponsor Collaborator
Ankara Diskapi Training and Research Hospital

Country where clinical trial is conducted

Turkey, 

References & Publications (5)

Agarwal A, Yadav G, Gupta D, Singh PK, Singh U. Evaluation of intra-operative tramadol for prevention of catheter-related bladder discomfort: a prospective, randomized, double-blind study. Br J Anaesth. 2008 Oct;101(4):506-10. doi: 10.1093/bja/aen217. Epub 2008 Jul 24. — View Citation

Akça B, Aydogan-Eren E, Canbay Ö, Karagöz AH, Üzümcügil F, Ankay-Yilbas A, Çelebi N. Comparison of efficacy of prophylactic ketamine and dexmedetomidine on postoperative bladder catheter-related discomfort. Saudi Med J. 2016 Jan;37(1):55-9. doi: 10.15537/smj.2016.1.14122. — View Citation

Hur M, Park SK, Yoon HK, Yoo S, Lee HC, Kim WH, Kim JT, Ku JH, Bahk JH. Comparative effectiveness of interventions for managing postoperative catheter-related bladder discomfort: a systematic review and network meta-analysis. J Anesth. 2019 Apr;33(2):197-208. doi: 10.1007/s00540-018-2597-2. Epub 2019 Jan 2. — View Citation

Kim HC, Lee YH, Jeon YT, Hwang JW, Lim YJ, Park JE, Park HP. The effect of intraoperative dexmedetomidine on postoperative catheter-related bladder discomfort in patients undergoing transurethral bladder tumour resection: A double-blind randomised study. Eur J Anaesthesiol. 2015 Sep;32(9):596-601. doi: 10.1097/EJA.0000000000000196. — View Citation

Li S, Song L, Ma Y, Lin X. Tramadol for the treatment of catheter-related bladder discomfort: a randomized controlled trial. BMC Anesthesiol. 2018 Dec 20;18(1):194. doi: 10.1186/s12871-018-0659-5. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary the severity of CRBD none - mild- moderate- severe 0. hour
Primary the severity of CRBD none - mild- moderate- severe 1. hour
Primary the severity of CRBD none - mild- moderate- severe 3. hour
Primary the severity of CRBD none - mild- moderate- severe 6. hour
Secondary 11-point numerical rating scale (NRS) 11-point numerical rating scale for pain (0='no pain' and 10='worst pain possible pain') were explained 24 hours
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06465121 - Difficult Intravenous Access in Pediatric Patients: Paramedical Care Using Ultrasound Guidance N/A
Completed NCT04454970 - Safe Access for Bladder Entry in Transgender Men Following Penile Reconstruction N/A
Recruiting NCT05860231 - Comparative Study Between Foley and T-Control® Catheter in Patients With Long-term Catheterization N/A
Recruiting NCT05334225 - Assessing the Knowledge and Self-confidence of Healthcare Workers to Perform Transurethral Catheterization: A Multicenter Survey
Recruiting NCT04140916 - Comparison of Two Peripheral Inserted Intravenous Catheters N/A
Not yet recruiting NCT06019897 - Impact of Tubing Colonization on the Incidence of Central Venous Catheter Infection
Completed NCT04811430 - Efficiency, and Emergency Department Nurse Preference Between 2 Methods of Visualization: A Pilot Study
Recruiting NCT05741866 - Novel Antimicrobial Dressing in Peripheral Intravenous Catheters (PIVCs) N/A
Recruiting NCT03924583 - Duplex Ultrasonography Performed by Nurses
Completed NCT04683302 - 3D Guided Internal Jugular Vein Catheterization N/A
Completed NCT04814745 - Intrathecal Morphine for Radical Robot Assisted Prostatectomy (TORNADO) N/A
Completed NCT05948878 - An Innovative Taping Technique for Improved Intravenous (IV) Catheter Securement N/A
Recruiting NCT05931887 - Evaluation of the Novel Silq ClearTract Catheter in Patients With Chronic Urinary Retention N/A
Not yet recruiting NCT06433739 - Efficacy of a Clinical Algorithm for the Selection of Peripheral Venous Catheters
Not yet recruiting NCT06466226 - Complications Associated With Multiple Central Venous Accesses in the Internal Jugular Vein N/A
Completed NCT05130762 - An Observational Study to Evaluate BD PureHubâ„¢ Disinfecting Cap Use on Needle-Free Connectors
Completed NCT05966909 - Incidence and Clinical Progression of Asymptomatic PICC-Related Thrombosis in Solid Cancer Patients
Recruiting NCT05284422 - Effect of Ultrasound-guided Insertion on Peripheral Catheters Related Complications. N/A
Completed NCT04772209 - Comparison of Effectiveness and Complications of Catheter Lock Solutions in Non-tunneled Hemodialysis Catheters N/A
Recruiting NCT05860634 - Urinary Catheter Self-Discontinuation After Urogynecology Surgery N/A